Dr. Rodney Ho (TLC-ART principal investigator) presented at the 2016 BioEngage Symposium: Imaging Tools Delivering on the Promise of Precision Cancer Treatment on May 25th, 2016 at the University of Washington Foege Hall Conference Room in Seattle, WA. The University of Washington Bioengineering Department invited Dr. Ho to speak for 15 minutes on, “High-resolution MRI and IR diagnostic imaging enabled by a novel biocompatible & biodegradable nano-platform,” during an hour long session chaired by Matt O’Donnell. This biodegradable, nano-platform supports TLC-ART as well as other related research programs that Dr. Ho is involved in. Specifically for TLC-ART, it allows for high-resolution, lymphatic and blood vessel MRI imaging. This imaging technique, as noted in Dr. Ho’s presentation, improves diagnostic functionality through greater contrast, higher resolutions, longer image acquisition times and is safer with lower dose requirements compared to more commonly used imaging techniques.
The purpose of BioEngage Symposium is to, “…explore new and existing imaging technologies helping guide surgeries, drive interventional procedures, and optimize personalized therapeutics. Faculty, post-docs, and students at all levels at UW…join[ed] with researchers from industry and selected clinicians to discuss current trends in the field, learn about each other’s research expertise, and promote potential research collaborations, development/translation projects, student projects, internships, and targeted recruiting.” More information on this symposium can be found through the linked source: http://uwbioengage.wix.com/symposium#!about/fun5o